Inhibitory effects of P2Y₁₂ receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes

References

• Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000;83:361–366.
   PubMed Web of Science ®Google Scholar
• Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost 2002;88:186–193.
   PubMed Web of Science ®Google Scholar
• Gachet C, Heckler B, Leon C, Vial C, Leray C, Ohlmann P, Cazenave JP. Activation of ADP receptors and platelet function. Thromb Haemost 1997;78:1500–1504.
   PubMedGoogle Scholar
• Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P2T receptor in amplification of human platelet activation, aggrega-tion, secretion and procoagulant activity. Br J Haematol 2000;110:925–934.
   PubMed Web of Science ®Google Scholar
• Kunapuli SP. Functional characterization of platelet ADP receptors. Platelets 1998;9:343–351.
   PubMed Web of Science ®Google Scholar
• The CURE Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345(7): 494–502.
   Google Scholar
• Hechler B, Eckly A, Ohlmann P, Cazenave JP, Gachet C. The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel. Br J Haematol 1998;103:858–866.
   PubMed Web of Science ®Google Scholar
• Geiger J, Brich P, Ho¨ nig-Liedl M, et al. Specific impairment of human platelet P2YAC ADP receptor-mediated signaling by the antiplatelet drug clopidogrel. Arterioscler Thromb Vasc Biol 1999;19:2007–2011.
   Google Scholar
• Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222–232.
   PubMed Web of Science ®Google Scholar
• Di Virgillo F, Chiozzi P, Ferrari D, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587–600.
   PubMedGoogle Scholar
• Mahaut-Smith MP, Ennion SJ, Rolf MG, Evans RJ. ADP is not an agonist at P2X1 receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. Br J Pharmacol 2000;131:108–114.
   PubMedGoogle Scholar
• Rolf MG, Mahaut-Smith MP. Effects of enhanced P2X1 receptor Ca2þ influx on functional responses in human platelets. Thromb Haemost 2002;88:495–502.
   PubMedGoogle Scholar
• Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999;19:2841–2846.
   PubMed Web of Science ®Google Scholar
• Monroe MM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381–1389.
   PubMed Web of Science ®Google Scholar
• Carmen-Martinez M, Martin S, Toti F, Fressinaud E, Dachary-Prigent J, Meyer D, Freyssinet JM. Significance of capacitance Ca2þ entry in the regulation of phosphatidylserine expression at the surface of stimulated cells. Biochemistry 1999;38:10092–10098.
   PubMedGoogle Scholar
• Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2þ-ATPase inhibitors. Biochemistry 1995;34:11625–11634.
   PubMed Web of Science ®Google Scholar
• Briede JJ, Heemskerk JW, Hemker C, Lindhout T. Heterogeneity in microparticle formation and exposure of anionic phospholipids at the plasma membrane of single adherent platelets. Biochim Biophys Acta 1999;1451:163–172.
   PubMedGoogle Scholar
• Zwaal RFA, Schroit AJ Pathophysiological implications ofmembrane phospholipid asymmetry in blood cells. Blood 1997;89:1121–1132.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Zhao J, Stout JG, Luhm RA, Wiedmer T, Sims PJ. Molecular cloning of human plasma membrane phospholipid scramblase. J Biol Chem 1997;272:18240–18244.
   PubMed Web of Science ®Google Scholar
• Leon C, Ravenat C, Freund M, Cazenave JP, Gachet C. Differential involvement of the P2Y1 and the P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol 2003;23:1941–1947.
   PubMed Web of Science ®Google Scholar
• Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV, Tam C, Coughlin SR. A dual thrombin receptor system for platelet activation. Nature 1998;394:690–694.
   PubMed Web of Science ®Google Scholar
• Savi P, Nurden P, Levy-Toledano S, Herbert JM. Clopidogrel: a review of its mechanism of action. Platelets 1998;9:251–255.
   PubMed Web of Science ®Google Scholar
• Savi P, Heilmann E, Nurden P, Laplace MC, Bihour C, Kieffer G, Nurden AT, Herbert JM. Clopidogrel: an antithrombotic drug acting on the ADP-dependent activation pathway of human platelets. Clin Appl Thromb Haemost 1996;2:35–42.
   Web of Science ®Google Scholar
• Storey RF, Oldroyd KG, Wilcox RG. Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thromb Haemost 2001;85:401–407.
   PubMed Web of Science ®Google Scholar
• Storey RF, Wilcox RG, Heptinstall S. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease. Platelets 2002;13:407–413.
   PubMed Web of Science ®Google Scholar
• Merrit JE, McCarthy SA, Davies MPA, Moores KE. Use of fluo-3 to measure cytosolic Ca2þ in platelets and neutrophils. Biochem J 1990;269:513–519.
   PubMed Web of Science ®Google Scholar
• Fox SC, Behan MWH, Heptinstall S. Inhibition of ADP-induced intracellular Ca2þ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1. Cell Calcium 2004;35:39–46.
   PubMed Web of Science ®Google Scholar
• Dorman D, Clemetson KJ, Kehrel B. The Gp1b thrombin binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000;96:2469–2478.
   PubMed Web of Science ®Google Scholar
• Ramstro¨m S, Ra°nby M, Lindahl TL. Platelet phosphatidyl-serine exposure and procoagulant activity in clotting whole blood-different effects of collagen, TRAP and calcium ionophore A23187. Thromb Haemost 2003;89:132–141.
   PubMedGoogle Scholar
• Weiss HJ, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb–IIIa deficiency, or impaired platelet coagulant activity-a comparison with Scott syndrome. Blood 1997; 89(5): 1599–1611.
   PubMedGoogle Scholar
• Brooks MB, Catalfamo JL, Alex Brown H, Ivanova P, Lovaglio J. A hereditary bleeding disorder in dogs caused by a lack of platelet procoagulant activity. Blood 2002; 99(7): 2434–2441.
   PubMedGoogle Scholar
• Dachary-Prigent J, Pasquet JM, Fressinaud E, Toti F, Freyssinet JM, Nurden AT. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphor-ylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. Br J Haematol. 1997; 99(4): 959–967.
   PubMedGoogle Scholar
• Vidal C, Spaulding C, Picard F, Schaison F, Melle J, Weber S, Fontenay-Roupe M. Flow cytometry detection of platelet procoagulant activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001;86:784–790.
   PubMedGoogle Scholar
• Leon C, Meike A, Klocke A, Morgenstren E, Moosbauer C, Eckly A, Spannag M, Gachet C, Engelmann B. Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood 2004;103:594–600.
   PubMed Web of Science ®Google Scholar